The recent announcement of novel, viable viruses created by artificial intelligence (AI) was celebrated as a major advance in the fight against antibiotic resistance. But it also raised urgent concerns about regulation.
The recent announcement of novel, viable viruses created by artificial intelligence (AI) was celebrated as a major advance in the fight against antibiotic resistance. But it also raised urgent concerns about regulation.
source & further reading
realclearhealth.com — original article
AI Bioweapons: How to Mail-Order a Pandemic Virus
What Big Pharma's Q2 Results Tell Us
AI in Drug R&D: At Last, the End of the Beginning